{{Rsnum
|rsid=11864477
|Gene=ADAMTS18
|Chromosome=16
|position=77393872
|Orientation=plus
|GMAF=0.1015
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
|Gene_s=ADAMTS18
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 0.9 | 11.5 | 87.6
| HCB | 0.0 | 8.8 | 91.2
| JPT | 0.0 | 3.5 | 96.5
| YRI | 4.8 | 37.0 | 58.2
| ASW | 1.8 | 29.8 | 68.4
| CHB | 0.0 | 8.8 | 91.2
| CHD | 0.9 | 6.4 | 92.7
| GIH | 0.0 | 25.7 | 74.3
| LWK | 3.6 | 43.6 | 52.7
| MEX | 1.7 | 20.7 | 77.6
| MKK | 7.1 | 39.1 | 53.8
| TSI | 0.0 | 15.7 | 84.3
| HapMapRevision=28
}}
{{PMID Auto GWAS
|PMID=19249006
|Trait=Bone mineral density
|Title=Genome-wide Association and Follow-Up Replication Studies Identified ADAMTS18 and TGFBR3 as Bone Mass Candidate Genes in Different Ethnic Groups
|RiskAllele=C
|Pval=2E-8
|OR=1.00
|ORtxt=% [NR] of variance explained
|OA=1
}}

{{omim
|desc=BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 13; BMND13
|id=612727
|rsnum=11864477
}}

{{PharmGKB
|RSID=rs11864477
|Name_s=
|Gene_s=ADAMTS18
|Feature=
|Evidence=PubMed ID:19249006; Web Resource:http://www.genome.gov/gwastudies/
|Annotation=GWAS results: Genome-wide Association and Follow-Up Replication Studies Identified ADAMTS18 and TGFBR3 as Bone Mass Candidate Genes in Different Ethnic Groups. (Initial Sample Size: 1,000 white individuals; Replication Sample Size: 4,925 white individuals, 350 Chinese hip fracture cases, 350 Chinese controls, 2,955 Chinese individuals, 908 West African men); (Region: 16q23.1; Reported Gene(s): ADAMTS18; Risk Allele: rs11864477-C); (p-value= 0.00000002).This variant is associated with Bone mineral density.
|Drugs=
|Drug Classes=
|Diseases=Bone Diseases; Bone Diseases, Metabolic; Fractures, Bone
|Curation Level=Non-Curated
|PharmGKB Accession ID=PA164739951
}}

{{PharmGKB
|RSID=rs11864477
|Name_s=
|Gene_s=ADAMTS18
|Feature=
|Evidence=PubMed ID:19249006
|Annotation=In a GWAS and follow-up eplication studies of 4,925 white individuals, 350 Chinese hip fracture cases, 350 Chinese controls, 2,955 Chinese individuals, and 908 West African men this variant in the ADAMTS18 gene was associated with bone mineral density, which is a prominent osteoporosis risk factor.
|Drugs=
|Drug Classes=
|Diseases=Osteoporosis
|Curation Level=Curated
|PharmGKB Accession ID=PA163522156
}}

{{GET Evidence
|impact=pathogenic
|qualified_impact=Insufficiently evaluated pathogenic
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs11864477
|overall_frequency_n=19
|overall_frequency_d=128
|overall_frequency=0.148438
|n_genomes=17
|n_genomes_annotated=0
|n_haplomes=20
|n_articles=1
|n_articles_annotated=0
|in_gwas=Y
|in_pharmgkb=Y
|autoscore=2
|webscore=N
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | HumanOmni1Quad}}